The link between LAP1 and neuromuscular transmission is suggested by the congenital myasthenic syndrome (CMS) phenotype that was first described in two patients with TOR1AIP1 mutations. This evidence concerns the gene TOR1AIP1 and Congenital myasthenic syndromes.